Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 2, Issue 1, 2003, Pages 19-24

  Mirakhur, A ^a   Gallagher, M J ^b   Ledson, M J ^a   Hart, C A ^a   Walshaw, M J ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Chronic colonisation; Combination antibiotic therapy; Novel treatments

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; CREATININE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TOBRAMYCIN; UREA;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; INFORMED CONSENT; KIDNEY FUNCTION TEST; MALE; MULTIDRUG RESISTANCE; NAUSEA; NEPHROTOXICITY; OTOTOXICITY; PREDICTION; PSEUDOMONAS AERUGINOSA; SPIROMETRY; SPUTUM CULTURE; SYMPTOMATOLOGY; TREATMENT OUTCOME; UREA BLOOD LEVEL;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CREATININE; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FOSFOMYCIN; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM;

EID: 0038779879     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(02)00143-1     Document Type: Article

References (35)

1. Mouton J.W. Hollander J. Horrevorts A.M. Emergence of antibiotic resistance amongst P. aeruginosa isolates from patients with cystic fibrosis J Antimicrob Chemother 31 1993 919-926
2. Matz G.J. Aminoglycoside cochlear ototoxicity Otolaryngol Clin North Am 26 1993 705-712
3. Walker P.D. Barri Y. Shah S.V. Oxidant mechanisms in gentamicin nephrotoxicity Renal Failure 21 1999 433-442
4. Cheng K. Smyth R. Govan J. et-al. Spread of β-lactam resistant Pseudomonas aeruginosa in a cystic fibrosis clinic Lancet 348 1996 639-642
5. Hendlin D. Stapley E.O. Jackson M. Wallick H. Miller A.K. Wolf F.J. et-al. Phosphonomycin, a new antibiotic produced by strains of Streptomyces Science 166 1969 122-123
6. Forsgren A. Walder M. Antimicrobial activity of fosfomycin in vitro J Antimicrob Chemoth 11 1983 467-471
7. Bergan T. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives Chemother 1 36 Suppl 1990 10-18
8. Shimizu K. Fosfomycin: Absorption and excretion Chemother 1 23 Suppl 1977 153-158
9. Kirby W.M. Pharmacokinetics of fosfomycin Chemother 1 23 Suppl 1977 141-151
10. Farago E. Kiss I.J. Nabradi Z. Serum and lung tissue levels of fosfomycin in humans Int J Clin Pharmacol Ther Toxicol 18 1980 554-558
11. Kahan F.M. Kahan J.S. Cassidy P.J. Kropp H. The mechanism of action of fosfomycin (phosphonomycin) Ann NY Acad Sci 235 1974 364-386
12. Reeves D.S. Fosfomycin trometamol J Antimicrob Chemother 34 1994 853-858
13. Morin J.P. Olier B. Voitte G. Fillastre J.P. Can fosfomycin reduce the nephrotoxicity of aminoglycosides? Pathol Biol (Paris) 32 1984 338-342
14. Inouye S. Niizato T. Takeda U. Koeda T. Protective effect of fosfomycin on the experimental nephrotoxicity induced by dibekacin J Pharmacobiodynam 5 1982 659-669
15. Ohtani I. Ohtsuki K. Aikawa T. Sato Y. Anzai T. Ouchi J. Mechanism of protective effect of fosfomycin against aminoglycoside ototoxicity Auris Nasus Larynx 11 1984 119-124
16. Ohtani I. Ohtsuki K. Aikawa T. Sato Y. Anzai T. Ouchi J. Saito T. Protective effect of fosfomycin against aminoglycoside ototoxicity ORL J Otorhinolaryngol Relat Spec 47 1985 42-48
17. Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. 1998. Antimicrobial Sensitivity Guidelines. British Society of Antimicrobial Chemotherapy. Birmingham, UK
18. Anwar H. Strap J.L. Costerton J.W. Establishment of ageing biofilms: possible mechanisms of bacterial resistance to antimicrobial therapy Antimicrob Ag Chemother 36 1992 1347-1351
19. Hoyle B.D. Costerton J.W. Bacterial resistance to antibiotics: the role of biofilms Prog Drug Res 37 1991 91-105
20. Costerton J.W. Lam J. Lam K. Chan R. The role of the microcolony mode of growth in the pathogenesis of Pseudomonas aeruginosa infections Rev Infect Dis 55 Suppl 5 1983 S867-S873
21. Kumon H. Tomochika K. Matanuga T. Ogawa M. Ohmori H. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides Microbiol Immunol 38 1994 615-619
22. Kumon H. Ono N. Iida M. Nickel J.C. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm Antimicrob Ag and Chemotherapy 39 1995 1038-1044
23. Figueredo V.M. Neu H.C. Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas aeruginosa isolates from patients with cystic fibrosis J Antimicrob Chemother 22 1988 41-50
24. Courcol R.J. Martin G.R. In vitro activity of the combination of ceftriaxone and fosfomycin against Staphylococci J Antimicrob Chemother 19 1987 276-278
25. Takahashi K. Kanno H. Synergistic activities of combinations of β-lactams, fosfomycin and tobramycin against Pseudomonas aeruginosa Antimicrob Ag Chemother 26 1984 789-791
26. Ulmann U. Lindemann B. In vitro investigations on the action of fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens Arzneimittelforschung 30 1980 1247-1249
27. Daza R. Moreno-Lopez M. Damaso D. Interactions of fosfomycin with other antibiotics Chemother 1 23 Suppl 1977 86-92
28. Tessier F. Quentin C. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin and ciprofloxacin against Pseudomonas aeruginosa Eur J Clin Microbiol Infect Dis 16 1997 159-162
29. Schulin T. In vitro activity of the aerosolised agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany J Antimicrob Chemother 49 2002 403-406
30. Woodruff H.B. Mata J.M. Hernandez S. Mochales S. Rodriguez A. Stapley E.O. et-al Fosfomycin: Laboratory studies Chemother 1 23 Suppl 1977 1-22
31. Inouye S. Niizato T. Komiya I. Yuda Y. Yamada Y. Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rat J Pharmacobiodynam 5 1982 941-950
32. Jardin A. A general practitioner multicentre study: fosfomycin trometamol single dose vs. pipemidic acid multiple dose Infection 2 18 Suppl 1990 S89-S93
33. MacGowan A.P. Bailey R.A. Egner W. Picken D.M. Reeves D.S. An open study of the efficacy and safety of single dose fosfomycin trometamol in the treatment of hospitalised patients with urinary tract infection (pilot study) Infection 2 18 Suppl 1990 S107-S108
34. Mayama T. Yokota M. Shimatani I. Ohyagi H. Analysis of oral fosfomycin calcium (Fosmicin) side effects after marketing Int J Clin Pharmacol Therap Toxicol 31 1993 77-82
35. Wolter J.M. Bowler S.D. McCormack J.G. Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis? Aust NZ J Med 29 1999 15-21